Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Liquidnet Expands Into US Equity Options
-
Cantor Fitzgerald Notes IPR&D Charge Impact on Abbvie's (ABBV) 3Q EPS
-
Cantor Fitzgerald Cuts BioMarin (BMRN) PT to $80 Ahead of 3Q Earnings
-
Cantor Fitzgerald Downgrades Tvardi Therapeutics Inc (TVRD) to Neutral
-
Cantor Fitzgerald Lowers Alexandria Real Estate (ARE) PT to $79 Amid Multiple Headwinds
-
Cantor Fitzgerald Raises Ascendis Pharma (ASND) PT to $254, Sees Steady New Patient Adds
-
Cantor Fitzgerald Reiterates Overweight on Vera Therapeutics (VERA); Says Shares Undervalued
-
Sprott Physical Platinum and Palladium Trust Updates its "At-the-Market" Equity Program
-
Cantor Fitzgerald Reiterates Overweight on CVS Health, Cites Strong Star Ratings
-
Trident Zoetic Strengthens Global Leadership Team to Advance Innovation in Rare Earths, Quantum Infrastructure, and Sustainable Technology
-
Rezolve Ai completes Smartpay and Subsquid deals for $10 million cash
-
Rezolve Ai Confirms Minimal Dilution from Foundational Acquisitions
-
Cantor Fitzgerald Reiterates Neutral on Humana (HUM), Notes 2026 MA Margin Improvement
-
Cantor Fitzgerald Reiterates Neutral on Molina Healthcare (MOH), Highlights 2026 Stars Progress
-
Cantor Fitzgerald Reiterates Overweight on UnitedHealth (UNH), Cites 4-Star Membership Gains
-
Cantor Fitzgerald Reiterates Overweight on Elevance (ELV), Cites 5-Star Membership Growth
-
Cantor Fitzgerald Reiterates Neutral on Centene, Highlights 2027 Break-Even Path
-
Cantor Fitzgerald Reiterates Neutral on Elastic (ESTC), Raises PT to $94 on AI Growth
-
Cantor Fitzgerald Reiterates Overweight Rating on Cabaletta Bio Inc. (CABA)
-
SunTx Capital Partners' Portfolio Company, Suncrete, to Pursue Listing on the New York Stock Exchange through a Proposed Business Combination with Haymaker Acquisition Corp. 4
-
NVIDIA (NVDA) PT raised to $300 at Cantor Fitzgerald on AI infrastructure growth
-
Cantor Fitzgerald Reiterates Overweight Rating on Travelers (TRV), Says Well-Positioned in SME
-
Cantor Fitzgerald Reiterates Overweight Rating on Vertex (VRTX)
-
Cantor Fitzgerald Reiterates Overweight Rating on Aon Corp (AON), Says It's Good Value
-
Freddie Mac launches tender offer for STACR notes worth over $1.5 billion
-
Freddie Mac Announces Tender Offer for Any and All of Certain STACR Notes
-
Cantor Fitzgerald Assumes Arcellx Inc. (ACLX) at Neutral
-
Cantor Fitzgerald Reiterates Overweight Rating on Phathom Pharmaceuticals (PHAT)
-
Cantor Fitzgerald Reiterates Overweight Rating on Regeneron Pharma (REGN)
-
Abbvie (ABBV) PT raised to $250 at Cantor Fitzgerald on Skyrizi, Vyalev gains
-
Cantor Fitzgerald Reiterates Overweight Rating on Goosehead Insurance Inc. (GSHD)
-
Fossil Announces Convening Hearing for Restructuring Plan
-
Predictive Oncology raises $343.5 million for digital asset strategy
-
Predictive Oncology Inc. Announces Closing of $343.5 Million in Private Placements to Initiate Digital Asset Treasury Strategy
-
Fossil extends exchange offer deadline to October 15
-
Fossil Announces Extension of Exchange Offer For Its Senior Notes
-
Arcus' (RCUS) presentation marks renewed innovation in RCC: Cantor Fitzgerald
-
Esperion prices $75 million stock offering at $2.50 per share
-
Esperion Announces Pricing of Public Offering of Common Stock
-
Esperion announces public offering of common stock
-
Esperion Announces Proposed Public Offering of Common Stock
-
Cantor Fitzgerald Upgrades Trilogy Metals (TMQ) to Buy
-
Cantor Fitzgerald reiterates Neutral rating on Universal Health (UHS)
-
Surgery Partners (SGRY): Q3 survey results more positive than guidance, says analyst
-
AST SpaceMobile files to sell up to $800 million in stock
-
Cantor Fitzgerald sees outpatient trends supporting Tenet Healthcare (THC)
-
Cantor Fitzgerald Most Optimistic about HCA Healthcare Inc (HCA) in Provider Group
-
Cantor Fitzgerald Reiterates Neutral Rating on Acadia Healthcare (ACHC)
-
Cantor Fitzgerald Starts Legend Biotech Corp. (LEGN) at Overweight
-
Cantor Fitzgerald Starts Gemini Space Station (GEMI) at Overweight

